A specialty pharmaceutical company leveraging its proprietary technologies to optimize the delivery of previously approved drug products. Lead products, HLD-100 and HLD-200, are novel formulations of the psychostimulants used to treat ADHD and are being developed to address a prevalent unmet medical need in the treatment of the disease. The clinically meaningful benefits of Highland's approach are targeted at helping ADHD patients and their families improve the quality of their lives. (BIOTECanada)